Effect of systemic inflammation biomarkers on overall survival after lung cancer radiotherapy: a single-center large-cohort study

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Moro-Sibilot D, Smit E, de Castro Carpeño J, et al. Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study. Lung Cancer. 2015;88(2):215–222.
   PubMed Web of Science ®Google Scholar
• Faivre-Finn C, Vicente D, Kurata T, et al. Four-Year survival with durvalumab after chemoradiotherapy in stage III NSCLC-an update from the PACIFIC trial. J Thora Oncol. 2021;16(5):860–867.
   PubMed Web of Science ®Google Scholar
• Deek MP, Benenati B, Kim S, et al. Thoracic vertebral body irradiation contributes to acute hematologic toxicity during chemoradiation therapy for Non-Small cell lung cancer. Int J Radiat Oncol Biol Phys. 2016;94(1):147–154.
   PubMed Web of Science ®Google Scholar
• Campian JL, Ye X, Brock M, et al. Treatment-related lymphopenia in patients with stage III Non-Small-Cell lung cancer. Cancer Investigation. 2013;31(3):183–188.
   PubMed Web of Science ®Google Scholar
• Abravan A, Eide HA, Løndalen AM, et al. Mapping bone marrow response in the vertebral column by positron emission tomography following radiotherapy and erlotinib therapy of lung cancer. Mol Imaging Biol. 2019;21(2):391–398. doi:https://doi.org/10.1007/s11307-018-1226-7.
   PubMed Web of Science ®Google Scholar
• Abravan A, Faivre-Finn C, Kennedy J, et al. Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer. J Thorac Oncol. 2020;15(10):1624–1635.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Zahorec R. Ratio of neutrophil to lymphocyte counts–rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5–14.
   PubMedGoogle Scholar
• Templeton AJ, McNamara MG, Šeruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. JNCI. 2014;106(6):dju124.
   Google Scholar
• Yao Y, Yuan D, Liu H, et al. Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy. Cancer Immunol Immunother. 2013;62(3):471–479.
   PubMed Web of Science ®Google Scholar
• Cedrés S, Torrejon D, Martínez A, et al. Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol. 2012;14(11):864–869.
   PubMed Web of Science ®Google Scholar
• Krenn-Pilko S, Langsenlehner U, Thurner EM, et al. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer. 2014;110(10):2524–2530.
   PubMed Web of Science ®Google Scholar
• Liu H, Wu Y, Wang Z, et al. Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer. J Thorac Dis. 2013;5(6):783–789.
   PubMed Web of Science ®Google Scholar
• Yin Y, Wang J, Wang X, et al. Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: a meta-analysis. Clinics (Sao Paulo). 2015;70(7):524–530.
   PubMed Web of Science ®Google Scholar
• Unal D, Eroglu C, Kurtul N, et al. Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev. 2013;14(9):5237–5242.
   PubMedGoogle Scholar
• Kang MH, Go SI, Song HN, et al. The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer. Br J Cancer. 2014;111(3):452–460.
   PubMed Web of Science ®Google Scholar
• Zhong JH, Huang D-H, Chen ZY. Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis. Oncotarget. 2017;8(43):75381–75388.
   PubMedGoogle Scholar
• Tong YS, Tan J, Zhou XL, et al. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer. J Transl Med. 2017;15(1):221.
   PubMed Web of Science ®Google Scholar
• Li X, Hu P, Liu J, et al. Systemic immune-inflammation index predicted overall survival and radiosensitivity in advanced non-small-cell lung cancer. Future Oncol. 2020;16(5):103–115.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen B, Wang L, et al. Systemic immune-inflammation index is a promising noninvasive marker to predict survival of lung cancer: a meta-analysis. Medicine. 2019;98(3):e13788-e.
   Web of Science ®Google Scholar
• Hong X, Cui B, Wang M, et al. Systemic immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer. Tohoku J Exp Med. 2015;236(4):297–304.
   PubMed Web of Science ®Google Scholar
• Schernberg A, Moureau-Zabotto L, Del Campo ER, et al. Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation. Oncotarget. 2017;8(7):11579–11588.
   PubMedGoogle Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–867.
   PubMed Web of Science ®Google Scholar
• Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion. Science. 2011;331(6024):1565–1570.
   PubMed Web of Science ®Google Scholar
• Chen F, Zhuang X, Lin L, et al. New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med. 2015;13(1):45.
   PubMed Web of Science ®Google Scholar
• Gooden MJM, de Bock GH, Leffers N, et al. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer. 2011;105(1):93–103.
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang S-H, Li H, et al. Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer. Med Oncol. 2013;30(1):352.
   PubMed Web of Science ®Google Scholar
• Treffers LW, Hiemstra IH, Kuijpers TW, et al. Neutrophils in cancer. Immunol Rev. 2016;273(1):312–328.
   PubMed Web of Science ®Google Scholar
• Grecian R, Whyte MKB, Walmsley SR. The role of neutrophils in cancer. Br Med Bull. 2018;128(1):5–14.
   PubMed Web of Science ®Google Scholar
• Campian J, Sarai G, Ye X, et al. The association between severe treatment-related lymphopenia and progression free survival in patients with newly diagnosed squamous cell head and neck cancer. Head Neck. 2014;36(12):1747–1753.
   PubMed Web of Science ®Google Scholar
• Tang C, Liao Z, Gomez D, et al. Lymphopenia association with gross tumor volume and lung V5 and its effects on Non-Small cell lung cancer patient outcomes. Int J Radiat Biol. 2014;89(5):1084–1091.
   Web of Science ®Google Scholar
• Schernberg A, Escande A, Rivin Del Campo E, et al. Leukocytosis and neutrophilia predicts outcome in anal cancer. Radiotherapy and Oncology. 2017;122(1):137–145.
   PubMed Web of Science ®Google Scholar
• Balmanoukian A, Ye X, Herman J, et al. The association between Treatment-Related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas. Cancer Investig. 2012;30(8):571–576.
   PubMed Web of Science ®Google Scholar
• Leblanc R, Houssin A, Peyruchaud O. Platelets, autotaxin and lysophosphatidic acid signalling: win-win factors for cancer metastasis. Br J Pharmacol. 2018;175(15):3100–3110.
   PubMed Web of Science ®Google Scholar
• Hughes MA, Parisi M, Grossman S, et al. Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection. Int J Radiat Biol. 2005;62(5):1423–1426.
   Web of Science ®Google Scholar
• Abravan A, Eide HA, Helland Å, et al. Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy. Clin Transl Rad Oncol. 2020;22:15–21.
   PubMed Web of Science ®Google Scholar